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THE G ALLELE AT THE 80TH NUCLEOTIDE OF THE RFCl GENE IS A GENETIC
RISK FACTOR FOR NONSYNDROMIC CLEFT LIP AND PALATE
1

2

Cory Costanzo , Marie Tolarova , Mirek Tolar3, Hee Soo Oh 1, Diana Grochova2 and Tripti
3
Pawar
1

Orthodontic Residency Program and 2 Craniofacial Genetics Laboratory, Department of
Orthodontics, School of Dentistry, University of the Pacific, 2155 Webster Street, San Francisco,
3
CA 94115; Pediatric Clinical Research Center, PCRC Core Laboratory, Children's Medical
Center, UCSF, 505 Parnassus Avenue, San Francisco, CA 94143
INTRODUCTION: Nonsyndromic cleft lip and palate (NCLP) is among the most common
congenital anomalies with a prevalence of approximately 1 in 700 live births. The etiology of
NCLP consists ofboth environmental and genetic factors, including folic acid intake and folic
acid metabolism. Because of their suspected importance, genes involved in the metabolism of
folic acid have been considered as candidate genes for the etiology ofNCLP.
OBJECTIVES:
Our study focused on a possible role of the reduced folate carrier 1
(RFC1) gene, which is involved in transporting folate across the cell membrane. We studied the
polymorphism at nucleotide 80 (A80G).
METHODS:
We investigated a sample of individuals affected with NCLP (n=97) and a
sample ofunaffected individuals (n=76) from the same location. Cases and controls were
identified during Rotaplast medical missions at Roosevelt Hospital in Guatemala City,
Guatemala. Diagnosis of cleft was determined by physical examination of each individual.
DNA was isolated from dry blood spots on filter paper. RFC1 A80G genotypes were established
by PCR amplification and single nucleotide conformational polymorphism detection using
polyacrylamide gel electrophoresis.
RESULTS:
A significant difference (x2 , p=0.0157) was found in genotype distribution
between cases and controls. In cases, 19.6% of individuals had A80/A80 genotype, 34.0% had
G80/G80 genotype, and 46.4% were heterozygotes (A80/G80). Proportions of genotypes in
controls were 39.5% A80/A80, 25.0% G80/G80, and 35.5% A80/G80. The A allele frequency
was 0.427 for cases and 0.572 for controls, while the G allele frequency was 0.573 for cases and
0.428 for controls (x2, p=0.0104, Odds ratio=0.56; 95% Confidence limits: 0.35, 0.88).
CONCLUSION:
Results ofthis study suggest that the G allele in nucleotide 80 ofthe RFC1
gene contributes to the etiology ofNCLP in Guatemala.
The fieldwork for this study was supported by Rotaplast Intl., DNA analysis was supported by
The Smile Train/PSEF grant.
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DIFFERENCES IN PROFILE CHANGE DURING TREATMENT IN EXTRACTION
AND NON-EXTRACTION PATIENTS

A. Kouvaris 1 and S. Baumrind2
1

2

Orthodontics Residency Program and Department of Orthodontics, School of Dentistry,
University of the Pacific, 2155 Webster Street, San Francisco, CA 94115

OBJECTIVE:
To investigate differences in the anterior hard and soft tissue changes
observed during treatment between class I and class II patients treated with and without four
bicuspid extraction.
METHOD:
This initial study sought to identify cephalometric variables whose change
during treatment differed as a function of four bicuspid extraction. A new random sample was
collected retrospectively in the practice of a single experienced orthodontist. The sample
included 48 growing subjects equally balanced (i.e., 24/24) for extraction/non-extraction, Class
1/Class II and Male/Female. All subjects had been treated using the full bonded Edgewise
appliance. Treatment-associated changes in seventeen hard and soft tissue linear and angular
measures were computed from triple determined landmark coordinates.
RESULTS:
Only seven ofthe seventeen measures had mean differences in change
during treatment in excess of one degree or one millimeter. These were Naso-Labial Angle2
(L13.13°), Interincisal Angle (L13.04°), Lower 1 to NB Angle (L12.36°), Naso-Labial Angle1
(L12.00°), Lower 1 to NB Distance (L11.42mm), Subnasale to Soft Tissue B point (L11.07mm), and
Subnasale to Upper Lip Anterior (L11.04mm). Only the differences in change for Lower 1 to NB
Distance were statistically significant (t = 2.44, p<0.02). For the other six measures, interindividual variability was too great to be sure the observed differences in mean were beyond the
probability of chance. It was noted that among the extraction cases (n=24), the retraction of the
lower incisor was statistically significantly but mildly associated with greater retraction of the
lower lip (r = 0.45, p<0.03). This association was not observed among the non-extraction cases (r
= 0.07, p< 0.76).
CONCLUSION:
In general, differences in change during treatment between extraction and
non-extraction patients did not appear to be sufficiently large to have substantially different
effects on the pretreatment profile.
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QUANTIFYING MAXILLARY 1sT MOLAR DISPLACEMENT ASSOCIATED WITH
NON-EXTRACTION, CLASS II CORRECTION IN A GROWING POPULATION
Tom Ellerhorst 1 and Sean Carlson2
1

2

Orthodontic Residency Program and Department of Orthodontics, School ofDentistry,
University of the Pacific, 2155 Webster Street, San Francisco, CA 94115

This retrospective study looked at pre and post-treatment lateral cephalographs to
quantify the displacement of maxillary first molars within the maxilla. Displacements of the MB
root apex and MB cusp tips, as well a the change in the molar angle were recorded through the
use of modified Bjork maxillary anatomic superimpositions and the establishment a coordinate
reference plane based on the palatal plane of the pre-treatment headfilm. Three distinct groups
of subjects (1 Begg sample and 2 Edgewise samples) treated by three separate clinicians were
used to develop a sample totaling 144 subjects, all younger than the age of 18 years upon
completion of treatment. A special emphasis was placed on class II non-extraction treatment.
The results demonstrated that the molars were displaced in a variety of directions during
successful treatment of these class II non-extraction cases. In all cases, extrusion occurred. In
the Begg sample, this extrusion was accompanied by minimal mesial molar movement (0.04mm
at the apex, 0.33mm at the cusp tip). In one ofthe Edgewise samples, the extrusion was
accompanied by molar distalization (-2.48mm at the apex, -0.69mm at the cusp tip), while the
other Edgewise sample demonstrated extrusion and mesialization (0.59mm at the apex, 3.52mm
at the cusp tip) ofthe maxillary first molar. In all cases, the molar angle decreased,
demonstrating a mesial tipping of the maxillary first molar during treatment. It was concluded
that the maxillary first molar can be displaced in a variety of directions in achieving successful
class II non-extraction treatment. Both the appliance type and the practitioner can have an effect
on the displacement of the molar.
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ASSOCIATION BETWEEN PREMOLAR EXTRACTIONS AND THE VERTICAL
DIMENSION

Shawn Perce 1 and Sean Carlson2

Orthodontics Residenc/ and Department of Orthodontici, School of Dentistry, University of the
Pacific, San Francisco, CA 94115
OBJECTIVE:
The present study was undertaken to investigate the influence of premolar
extractions on the vertical dimension.
METHODS:
In an effort to minimize bias, a "borderline" extraction sample was created
via retrospective analysis of the University of the Pacific Orthodontic Clinic Archives. This was
done to minimize the inherent differences of two samples with different pretreatment
characteristics. The vertical cephalometric changes of 32 patients (22 nonextraction, 10
extraction) were analyzed using a computer aided cephalometric technique to minimize
landmark identification error. The following pre and post treatment cephalometric variables
were acquired: mandibular plane angle, Y-axis, Oveljet, Overbite, upper face height, lower face
height, and total face height, maxillary molar position and mandibular molar position. Two
tailed student's t-tests were used to examine the differences in pretreatment (Tl), and
postreatment (T2) lateral cephalometric radiographs. The differences in the change incurred
during treatment (T2-Tl) between the two groups were also examined via t-tests.
RESULTS:
There were no statistically significant differences between the extraction
and nonextraction sample with regard to the vertical changes occurring during treatment.
CONCLUSION:
These data suggest that premolar extractions do not result in a decrease in
a patient's vertical dimension.
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CLINICIANS' ESTIMATES OF INCIDENCE OF TOOTH LOSS RELATED TO
APICAL ROOT RESORPTION
Vernon W. Pollock 1, Sheldon Baumrind2, Robeti L. Boyd2, Sean Carlson2
Residency Program and 2Department of Orthodontics, School of Dentistry,
University of the Pacific, 2155 Webster Street, San Francisco, CA 94115

1Orthodontics

Orthodontists are concerned that apical root resorption associated with full-bonded
treatment is occasionally of sufficient magnitude to contribute substantially to the loss of one or
more petmanent teeth. This pilot study is an initial attempt to survey dental clinicians'
perception of the incidence of such events in normal clinical practice. In this preliminary
survey, a five-item questionnaire was executed by a self-selected sample of 57 practicing dental
clinicians attending the 2003 Annual Meeting of the Alumni Association of the UOP School of
Dentistry. (Total Years in Practice= 668, Mean= 14.5, Range= 6 to 46.) Embedded among
several masking questions was the key inquiry asking how often each practitioner had found it
necessary to order the removal of one or more permanent teeth in which the major contributing
factor was apical root resorption associated with orthodontic treatment. Masking questions
solicited information on the incidence of tooth loss from other causes. Only 15 of the 57
clinicians (~ 1I 4) recalled ever having been required to order permanent tooth removal as a
consequence of apical resorption associated with orthodontic treatment. Among the clinicians
responding to this query, root resorption associated with orthodontic treatment was only rarely
the primary cause of tooth loss in the permanent dentition.
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DO REPEATED CLINICAL COMPETENCY RATINGS STEREOTYPE STUDENTS?
David W. Chambers 1
1

Department ofAcademic Affairs, School of Dentistry, University of the Pacific, 2155 Webster
Street, San Francisco, CA 94115

Stereotypes are judgments that are incomplete summaries, based in part on non-essential
characteristics that distort or prevent accurate use of new information. Faculty ratings of student clinical
competency over the final two years of the educational program in the University of the Pacific School of
Dentistry in areas of clinical judgment, patient management, and technical skill were analyzed. This
represented 149 students with eight sets of ratings comprising an average of 16.2 faculty ratings per
student. Ratings were classified as P = rating by a faculty member of a student during a particular quarter
when the same faculty member also rated the same student the next quarter, N =rating by a faculty
member of a student whom that faculty member did not rate the previous quarter, and R =rating by a
faculty member of a student in a subsequent quarter after having been rated by the same faculty member
the previous quarter. PR correlations across quarters (repeated evaluations by the same instructor) tend to
be higher than PN correlations (evaluations of the same student by different faculty members). Using
partial correlation (holding new ratings constant) shows that the proportion of experience carried over
begins at about 10% at the start of each year and rises to about 20% by the end of first year and to about
50% by the end of second year. However, prediction of graduation quarter competence is significantly
better for faculty members who perform repeat evaluations. It is concluded that faculty do carry their
knowledge of prior student experience over to subsequent ratings of students, but that this knowledge is
more accurate than is the knowledge of first-time faculty raters .

12

r

4

ELECTROKINETICS OF STEALTH® LIPOSOMES

Valentina A Khorosheva 1 and Joel A Cohen 1
Department of Physiology, School of Dentistry, University of the Pacific, · 215 5 Webster Street,
San Francisco, CA 94115

Liposomes are colloidal particles composed of lipids. Liposomes decorated with surface"'grafted poly (ethylene glycol) (PEG) polymers, known as sterically-stabilized or Stealth®
liposomes, are in current therapeutic use for intravenous delivery of anti-cancer and anti-fungal
drugs. Dental applications for oral cancer and antibiotic therapy are being evaluated. The
"hairy" polymer coating retards recognition of the liposome by the host immune system, buying
valuable time for systemic circulation and therapeutic activity. To elucidate the physical
structure of the polymer coats, we measured electrophoretic mobilities of a series of such
liposomes, determining their hydrodynamic drag under various conditions. End-grafted PEGs
ranged in size from 2 to 113 monomers; nominal PEG grafting densities ranged from one PEG
chain per 200 lipids to one PEG chain per 10 lipids; and NaCl ionic strength ranged from 0.5
mM to 100 mM. The liposome surface-charge density was held constant at one negative charge
per 10 lipids by appropriate inclusion of charged non-PEGylated lipids. Identically charged
liposomes having no grafted PEG served as controls. The observed drag effects are large: they
reduce the motilities by up to 90%. The investigated polymer lengths and grafting densities span
the mushroom-to-brush transition. The mobilities are analyzed to yield hydrodynamic coat
thicknesses, polymer-water frictional coefficients, and polymer segment-density profiles. These
studies are of practical significance in the future design of liposomes for drug delivery.
(Supported in part by the Pacific Dental Research Foundation)
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CHARACTERIZATION OF KANAMYCIN AS A SELECTABLE MARKER FOR
MULTICOPY TRANSFORMANTS IN P. PASTORIS
Matthew Hashimoto 1, Christopher Hatae 1, Geoff & Joan Lin-Cereghino 1
1

Department of Biological Sciences, University ofthe Pacific, 3601 Pacific Avenue, Stockton, CA
95211

The yeast Pichia pastoris is commonly used as a host organism in heterologous protein
expression, which is a process that is utilized to produce many pharmaceuticals and other
industrial products. One of the main problems of P. pastoris is that it does not have a wide range
of selectable markers available for use in transformation and expression processes. This being
the case, the use of P. pastoris can be expensive in that one of the few efficient selectable
markers on hand is the zeocin resistance gene. Currently only one company, Invitrogen,
distributes a commonly used reporter gene, the zeocin resistance gene. Zeocin is an antibiotic
that binds to the DNA of a cell (e.g. P. pastoris) and cleaves it causing cell death. In this
experiment we will attempt to adapt a kanamycin resistance selectable marker to fulfill the same
function of the zeocin resistance selectable marker. By creating a new selectable marker using
kanamycin resistance the costs of transformation in lab research will be cut drastically. With this
new cassette for a selectable marker we hope to open the market for other researchers enabling
them to be economically efficient in the lab.
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CELL-SURFACE HEPARAN SULFATE AND HIV-1 INFECTION OF DIFFERENTIATED
THP-1 CELLS
K. Konopka 1, A. Lee* 1.2, J. Monzon-Duller 1, and N. Dtizgtine~ 1
Department ofMicrobiology and 2 Doctor of Dental Surgery Program, University of the Pacific, School
of Dentistry, 215 5 Webster Street, San Francisco, CA 94115
1

OBJECTIVES:
Recently, it has been reported that the cell surface glycosaminoglycan, heparan
sulfate (HS), mediates the attachment of HIV to adherent cells expressing low CD4, such as HeLa-CD4
cells or macrophages, prior to virus entry. The established monocytic THP-1 cell line has been used to
study HIV -monocyte/macrophage interactions and the relationship between differentiation, virus
production and virus latency. Treatment with phorbol myristate acetate (PMA) induces differentiation of
THP-1 cells into adherent macrophage-like cells, which are susceptible to M-tropic, CCR5-dependent
HIV isolates. Differentiation ofTHP-1 cells markedly reduces CD4 surface expression (Konopka &
Duzgunes, AIDS Res. Hum. Retroviruses 2002,·18:123-131). Here we examined ifHS is involved in HIV
binding and infectivity in differentiated THP-1 cells.
METHODS:
PMA-treated THP-1 (THP-1/PMA) cells were incubated with either heparinase
(heparin-specific) or heparitinase I (HS-specific) for 2 hat 37°C. Expression ofHS on the surface of
THP-1 cells was examined using a fluorescent Monoclonal Anti-HS (1 OE4 epitope) antibody. Infection
ofTHP-1 cells with theM-tropic HIV-1BaL isolate and HIV binding were monitored by ELISA
determination ofp24 antigen in harvested culture supernatants and celllysates, respectively.
RESULTS:
PMA-treatment resulted in an upregulation ofHS expression. Over 40% ofTHP1/PMA cells tested highly positive for HS expression (Mean Fluorescence Intensity, MFI = 22.5) when
compared to 4.0% (MFI=5.4) for THP-1 cells growing in suspension. Treatment with the HS-specific
heparitinase I reduced expression ofHS by over 60%. Treatment with heparinases, however, did not
reduce HIV binding and did not affect HIV infection in THP-1/PMA cells.
CONCLUSIONS:
of cell-surface HS.

Our results suggest that HIV infection in THP-1/PMA cells may be independent

(This work was supported partially by the Pacific Dental Research Foundation, Grant 521)
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AMBISOME INHIBITS THE ADHERENCE OF CANDIDA ALBICANS TO HELA
CELLS

K. Konopka , B. Dorocka-Bobkowska2, and N. Dtizgtine~
1

1

1

Department ofMicrobiology, University of the Pacific, School of Dentistry, 2155 Webster
Street, San Francisco, CA 94115; 2 University of Medical Sciences, Poznan, Poland
OBJECTIVES:
Candida! adherence to epithelial cells is significantly reduced when
antifungal polyenes are present during the "adherence phase", but the treatment does not result in
detachment of cell-associated yeasts. It has been reported that Candida biofilms with reduced
susceptibility to conventional antifungals, are sensitive to lipid formulations of amphotericin B
(AMB). Here we examined the effect of AmBisome, the liposomal AMB formulation, and free
AMB on the adherence of C. albicans to HeLa cells.
METHODS:
The adherence of C. albicans to HeLa cells was determined as described
by Samaranayake et al. (1994). Cells were either incubated with Candida in the presence of the
drug or pre-incubated with yeasts for 1 hr at 37°C and subsequently exposed to the drug. The
cytotoxic effect of the drugs on HeLa cells was determined by an Alamar Blue assay.
RESULTS:
AmBisome was not toxic in the range 1-256 )lg/ml, while AMB was
toxic above 4 )lg/ml. Following the 1 hr incubation, in the presence of AMB at 1 and 4 )lg/ml,
the adherence of C. albicans was reduced by 58 and 71%, respectively. Under these conditions,
AmBisome at 1, 4, 16, 64 and 256 )lg/ml reduced adherence by 54, 63, 70, 76, and 83%,
respectively. These values were significantly different from the controls (P < 0.0005). The
susceptibility of cell-associated Candida to AMB and AmBisome was significantly lower. The
reduction in adherence was between 4 and 10%, when compared to the drug-free controls. The
values obtained for AmBisome at 16, 64 and 256 )lg/ml were significantly different from the
controls (P < 0.05).
CONCLUSIONS:
The liposomal AMB formulation, AmBisome, which is not toxic in a wide
range of concentrations, inhibits candida! colonization when present during the "adherence
phase", while the cell-associated Candida yeasts are highly resistant to antifungals in terms of
adherence.
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AMBISOME INHIBITS THE ADHERENCE OF CANDIDA ALBICANS TO HELA
CELLS
K. Konopka 1, B. Dorocka-Bobkowska2, and N. Duzgune~ 1
1

Department of Microbiology, University of the Pacific, School of Dentistry, 2155 Webster
Street, San Francisco, CA 941 I 5; 2 University of Medical Sciences, Poznan, Poland

OBJECTIVES:
Candida} adherence to epithelial cells is significantly reduced when
antifungal polyenes are present during the "adherence phase", but the treatment does not result in
detachment of cell-associated yeasts. It has been reported that Candida biofilms with reduced
susceptibility to conventional antifungals, are sensitive to lipid formulations of amphotericin B
(AMB). Here we examined the effect of AmBisome, the liposomal AMB formulation, and free
AMB on the adherence of C. albicans to HeLa cells.
METHODS:
The adherence of C. albicans to HeLa cells was determined as described
by Samaranayake et al. (1994). Cells were either incubated with Candida in the presence of the
drug or pre-incubated with yeasts for 1 hr at 37°C and subsequently exposed to the drug. The
cytotoxic effect of the drugs on HeLa cells was determined by an Alamar Blue assay.
RESULTS:
AmBisome was not toxic in the range 1 - 256 ~g/ml, while AMB was
toxic above 4 ~g/ml. Following the 1 hr incubation, in the presence of AMB at 1 and 4 ~g/ml ,
the adherence of C. albicans was reduced by 58 and 71%, respectively. Under these conditions,
AmBisome at 1, 4, 16, 64 and 256 ~g/ml reduced adherence by 54, 63, 70, 76, and 83%,
respectively. These values were significantly different from the controls (P < 0.0005). The
susceptibility of cell-associated Candida to AMB and AmBisome was significantly lower. The
reduction in adherence was between 4 and 10%, when compared to the drug-free controls. The
values obtained for AmBisome at 16, 64 and 256 ~g/ml were significantly different from the
controls (P < 0.05).
CONCLUSIONS:
The liposomal AMB formulation, AmBisome, which is not toxic in a wide
range of concentrations, inhibits candidal colonization when present during the "adherence
phase", while the cell-associated Candida yeasts are highly resistant to antifungals in terms of
adherence.
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AN EVALUATION OF THE USE OF AN ARTIFICIAL NEURAL NETWORK TO
PREDICT THE RISK FOR ADVERSE DRUG REACTIONS FROM LOW-DOSE
ASPIRIN CHEMOPROPHYLAXIS
Ninad Pati1 1 and Timothy J. Smith2
and Chemical Sciences Program and 2Department of Pharmacology and
Physiology, T J Long School of Pharmacy, University of the Pacific, Stockton, CA
1Pharmaceutical

Artificial Neural Networks (ANNs) are software programs inspired by and designed to
simulate the way in which the animal brain is supposed to process information. The
"intelligence" of the biological brain arises from its capability for learning, analysis, prediction
and recognition. Though the complexity of the biological brain is far greater than the present-day
neural network models, ANNs have shown an impressive ability for learning from data sets and
detection of non-linear hidden relationships not elicited by conventional statistical methods.
Over the last decade, many studies have been published demonstrating the efficacy of ANNs in
the biomedical field; especially for the diagnosis and prognosis of diseases, and
Pharmacokinetic-Pharmacodynamic modeling.
Our laboratory is evaluating the application of ANNs in the field of adverse drug reactions
(ADRs); as to whether the risk of their occurrence in a patient can be predicted from his/her
physiological or pathological parameters. Aspirin, at low doses (81-325mg/day), is commonly
advised after the age of 50 as a blood-thinning agent for the prophylaxis of coronary heart
disease. Gastrointestinal side-effects with its use are of particular concern, especially in the
elderly population.
We are currently working on data obtained from a prospective study on patients in a hospitalized
geriatric population (>70 yrs), followed over a period of 5 months. The patients were evaluated
by two geriatricians and two clinical pharmacists at the start and end points ofthe study; with
respect to drug therapy, medical history, laboratory data and ADRs. A portion of this data was
used to train NeuralWorks Predict, a commercially available ANN and construct several
tentative models for prediction of ADRs to low-dose aspirin. Another subset of this data was
kept aside to be used for testing these models.
Preliminary results indicate that a model trained using Blood platelet count (PC), Prothrombin
time (PT), Partial Thromboplastin Time (PTT) and Blood glucose levels show some potential for
use in predicting the risk of occurrence of ADRs to Aspirin, at the low doses used for
chemoprevention. Validation of these ANN models using external data from another hospital is
still pending.
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FACTORS AT PLAY IN CLEFTING. AN EPIDEMIOLOGICAL STUDY SEARCHING
FOR VARIOUS FACTORS CAUSING CLEFT LIP AND PALATE ANOMALIES IN
CEBU CITY, PHILIPPINES.
Tripti Pawar 1' 2, Miroslav Tolar2 and Marie Tolarova 1
1

Craniofacial Genetics Laboratory, Department of Orthodontics, School of Dentistry, University
2
of Pacific, 2155 Webster Street, San Francisco, CA 941 I 5; Pediatric Clinical Research Center,
PCRC Core Laboratory, Children's Medical Center, UCSF, 505 Parnassus Avenue, San
Francisco, CA 94143
Cleft lip and palate anomalies, including syndromes and multiple congenital anomalies,
affect one out of every 550 newborns in most countries with adequate registries. With the world
population on a steady rise, there is an increasing need for research to evaluate the role of both
environmental and genetic factors in the etiology of clefts.
Our study population came from the island province of Cebu, Philippines. We looked at 104
individuals affected with orofacial clefts and 76 controls (patients without a congenital anomaly).
A spectrum of factors such as sex distribution, age, family history, birth order, age of the mother
at the time ofbirth of the index child, and month ofbirth were evaluated.
The mean age of patients with an orofacial cleft was 7.9 years, a majority of which (72%) had
cleft lip and palate. The mean age for controls was 4.26 years. Among cases, the left side was
more often affected (71 %) than the right side, a result similar to that reported by others.
A family history of clefting was positive in 60% of cases. The mean value for birth order was
3.4. A higher birth order was found in cases affected with bilateral clefts (3.9); however this
difference was not statistically significant. The mean maternal age at the time of the child's birth
was 27.4 years for cases and 26.1 years for controls. When maternal age was analyzed by twoyears age groups, the majority of case mothers (23 .91 %) fell in the 24-26 years age group, and
the majority of control mothers fell in the 18 to 20 years age group.
A three-month weighted average of the month of birth of cases and controls showed two peaksone for the months of May to July and one for the months of September to November. Projected
to the time of conception, these peaks showed that a high number of affected individuals were
conceived in the months of September to November (end ofthe rainy season in the region) and
in the period from December to February (the dry season).
This pilot epidemiological study evaluates several variables that are historically considered as
risk factors for congenital anomalies. More extensive analysis of environmental, nutritional, and
genetic factors is in progress to determine the factors in the etiology of cleft lip and palate in this
Southeast Asian region.
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As many as 700 children are born every day with orofacial cleft in the world. One baby
every two minutes. The treatment of cleft anomalies has tremendously improved and many
children with a cleft have a normal life. However, with projected population increase, a number
of individuals affected with a cleft will increase, if we do not invest in prevention. Our research
and studies by others have shown that a significant proportion of nonsyndromic cleft lip and
palate (NCLP) can be prevented by peri conceptional supplementation with folic acid (FA).
OBJECTIVE:

To update a protocol for primary prevention ofNCLP.

METHOD:
We combined results of our studies and works by others focused on
environmental and genetic factors, and mothers' nutrition in relation to NCLP etiology.

RESULTS:
Different daily doses ofFA administered periconceptionally are needed
for prevention of occurrences and recurrences. Our previous studies showed a decrease of
recurrences by 65% when multivitamins and 10 mg ofFA were daily administered to the mother,
and a decrease of occurrences by 27-50% when 400 meg ofFA were daily obtained by the
mother from her diet. Mother's diet low in FA and zinc, especially when genetic susceptibility is
increased by mutations of candidate genes (C677T mutation of the methylenetetrahydrofolate
gene, A80G mutation of the reduced folate carrier 1 gene) increases a risk for having a baby
affected with NCLP. A spectrum of environmental and genetic factors was found to differ in
each location studied.
CONCLUSION:
Detailed data on mother's nutrition, lifestyle, medical and genetic history
combined with ascertainment of mutations in candidate genes are suggested for individual
prevention protocols, while considering a baseline information from an appropriate population
and location.
The studies included in this presentation were supported by Rotaplast International and by The
Smile Train/PSEF.
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IMPACT OF PATERNAL METHYLENETETRAHYDROFOLATE REDUCTASE
GENE (MTHFR) 677CT MUTATION ON FACIAL CLEFTS
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Evidence suggests that both genetic and environmental factors play a role in the etiology
of cleft lip and palate. It has been long understood that folate metabolism is critical for normal,
healthy prenatal development. For some time, the 677CT mutation of the
methylenetetrahydrofolate reductase gene (MTHFR) has been considered a genetic risk factor
for non-syndromic CLIP. MTHFR plays a crucial role in the folate metabolic pathway and its
677CT variant (leading to an alanine to valine substitution) results in a thermolabile enzyme and
decreased production of folate. An individual carrying the mutated allele in homozygotic
condition (677TT) has a 50% compromised capacity for processing dietary folate. However, a
high-dose of folic acid supplementation may overcome this disadvantage. Therefore,
understanding the genetic profile of individuals affected with a cleft - and those unaffected but
related to cleft patients - is fundamental for cleft prevention.
In any given individual, the genetic mutation that we are observing can either be inherited from a
parent or may occur on its own as a fresh mutation. Historically, research in this area has focused
on the mother and affected child.

This pilot study attempts to look at the genotypes of the fathers of affected children and examine
the paternal genetic contribution in respect ofMRHFR polymorphism.
MATERIALS AND METHODS: The cases for this pilot study were collected during
Rotaplast medical missions to Guatemala City, Guatemala in 2001 and 2002. They were fathers
of children affected with cleft lip or with cleft lip and palate. We selected 36 families. Blood was
drawn, subsequently spotted on filter paper and DNA was isolated from dry blood spots and
amplified using Polymerase Chain Reaction (PCR). Polyacrylamide Gel Electrophoresis (PAGE)
was used to establish MTHFR 677CT genotypes.
RESULTS:
Analysis ofpaternal genotypes showed that the wild type
homozygous CC genotype was present only in 4 (11.1 %) of36 fathers tested, the heterozygous
CT genotype in 15 (41.7%) and the homozygous TT genotype in 17 (47.2%). Thus, the
proportion of C toT alleles showed that the mutated T allele prevails (68.1 %).
CONCLUSION:
The results of our pilot study suggest a much stronger
paternal genetic contribution ofMTHFR 677CT polymorphism to the etiology ofnon-syndromic
clefts in Guatemala than expected. Further study on a larger sample and on a control population
IS m progress.
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SUICIDE GENE THERAPY FOR ORAL CANCER: APOPTOSIS OR NECROSIS?
Andrea Delurgio 1, Nate Overlid 2 , Krystyna Konopka2 and Nejat Duzgune~ 2
Doctor of Dental Surgery Program and 2Department of Microbiology, School of Dentistry,
University of the Pacific, 2155 Webster Street, San Francisco, CA 94115

1

Oral squamous cell carcinoma (SCC) is a disfiguring disease. It kills 31,000 people per
year in the United States and is still without an efficient, effective cure. Several gene therapy
approaches are being explored to treat oral SCC. "Suicide" gene therapy involves the delivery of
the Herpes Simplex Vims thymidine kinase (HSV -tk) gene to cancer cells followed by the
administration of the antiviral dmg ganciclovir, which is a nucleoside analog. The viral
thymidine kinase monophosphorylates ganciclovir, which is then di- and tri-phosphorylated by
cellular kinases. Tri-phosphorylated ganciclovir incorporates into replicating DNA during cell
division, and causes chain termination and eventually cell death. While this method has been
proven successful in killing cancer cells, the mechanism by which cell death is mediated in oral
SCC is not known. The aim ofthis study was to examine the mode of cytotoxicity, whether it is
via programmed cell death (apoptosis) or by necrosis. Human HSC-3 SCC cells were
transfected with the plasmid pCMVHSV -tk, using the cationic lipid reagent Metafectene, and
incubated with or without ganciclovir up to 9 days. Cell viability was ascertained by the
spectroscopic Alamar Blue assay on days 3, 6 and 9. The extent of necrosis was demarcated by
the entry of the dye, Propidium Iodide, into cells and its ability to stain nuclei red. Apoptosis
was ascertained by the binding of fluorescent Annexin V to phosphatidylserine exposed on the
outer leaflet of the plasma membrane, resulting in bright green fluorescence. While significant
ganciclovir-dependent cytotoxicity was observed, ganciclovir-independent cytotoxicity was also
noted. The latter may be attributed to cytotoxicity caused by the transfection procedure.
Fluorescence microscopy observations indicated that HSV -tk + ganciclovir-mediated
cytotoxicity was dominated by necrosis rather than apoptosis.
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CHILDREN AFFECTED WITH AN OROFACIAL CLEFT IN JIUJIANG, CHINA
AN EPIDEMIOLOGICAL STUDY.
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Cleft lip and palate anomalies that affect approximately one in every 700 newborns
worldwide are historically more common in Asian countries. Interestingly, this tendency was not
observed when prevalence of oro facial clefts was estimated among Asians who live in
California. The purpose of this pilot study was to investigate epidemiological characteristics of
children born with a cleft in the city of Jiujiang in the Jiangxi province of China.
The data were collected during personal interviews with mothers of children with a cleft or with
adult patients, in October 2002 during a Rotaplast medical mission. Data on 133 patients were
analyzed for this study. The patients' mean age was 7.6 years. The oldest patient was 48.3 years
old, the youngest was 2 months old. There was a predominance of males in our sample (male to
female ratio = 1.82). Patients were classified according to cleft diagnosis into six subgroups: CL
(cleft lip), CLP (cleft lip and palate), CP (cleft palate), Sy (syndrome), MCA (multiple congenital
anomalies), and unspecified type of orofacial cleft. The vast majority of our patients were
affected with CLP (42.85%), followed by CL (23.31 %). The mean birth weight of males was
3103.7 g; the mean birth weight of females was 2958.3 g. As we expected, a majority of our
patients were first born, because of the one-child policy in China. The mean birth order for male
patients was 1.9, and the mean birth order for female patients was 1.6. This difference, which
may reflect the preference for boys in Chinese families, was statistically significant (p= 0.012).
The mothers' mean age at the time ofbirth of a child with a cleft was 24.7 years. The youngest
mother was 9.4 years old, and the oldest mother was 40.3 years old.
Results of this pilot study give us a first, general overview of characteristics of patients affected
with orofacial clefts in Jiangxi province. More detailed evaluations of our cleft sample are in
progress.
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A STUDY OF FAMILIAL AND ENVIRONMENTAL RISK FACTORS FOR CLEFT LIP
AND PALATE, IN JIUJIANG, CHINA.
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Studies have shown that congenital anomalies such as cleft lip and palate have multiple
and complex risk factors, both genetic and environmental. In this pilot study of 133 families
with children with a cleft anomaly, we examined some of the factors affecting the development
of cleft lip and palate in the population of liujiang, China.
Among the environmental factors studied are: family history of congenital anomalies, birthplace,
location of residence, socioeconomic level, occupation of the parents during the index
pregnancy, mother's health problems and medication usage during pregnancy, mother's lifestyle,
number of children in the family, and availability of prenatal care.
The study confirms our hypothesis that there is an association between cleft lip and palate and a
positive family history (36.4%), residence in a rural countryside (62.2%), homebirths (47.4%),
and low family income (36%). There is also an association of cleft lip and palate with the
mother's health and lifestyle during pregnancy: 52% of mothers indicated they had suffered
from a cold sometime during their pregnancy, and 19.8% had taken either cold medicine or
antibiotics for that condition. Other specific details are required for further analyses of the type
and time of these fetal insults. Also, our results need confirmation in a case-control study.
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This study is based on 767 individuals from Venezuela (Barquisimeto and Cumana) and
Guatemala (Guatemala City). From these three populations the sample is comprised of 515 cases
of cleft lip with or without cleft palate (CL±P) and 252 controls (individuals without birth
defect).
Each subject was given a thorough physical exam followed by an extensive questionnaire and
interview. To evaluate associations of factors contributing to the etiology of CL±P, we analyzed
several epidemiological characteristics considered to be involved in causes of congenital
anomalies of orofacial region.
From previous studies we have learned that environmental as well as genetic factors are
"location specific", i.e. in different locations different factors may play a major role. Analysis of
parental age and birth order was undertaken using STATA version 8 software.
This study showed, that birth order of children born with cleft differed significantly between
controls and cases in all our three populations (p=0.006). Also other characteristics, like parental
age, seasonal incidence, place where family lived, and other, showed interesting results.
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Orofacial clefting is a congenital anomaly that occurs as a failure of structural facial
processes to fuse during the 51h to l2 1h week of gestation. Surgical repair is possible, but requires
a multidisciplinary approach. Prenatal detection with ultrasounds by well-trained technicians is a
beneficial tool that can help prepare parents emotionally and financially for the care of their
child. This investigation revealed that the frequency of misdiagnosis of prenatal diagnosis
occurs at an alarming rate in the 3 third world countries studied: Guatemala City, Guatemala;
Barquisimeto, Venezuela; and Cumana, Venezuela. Mothers of children with cleft lip and/or
palate that had an ultrasound during the pregnancy were asked if the congenital anomaly was
prenatally diagnosed. Overwhelming, at least 90% of cases studied were diagnosed incorrectly;
the highest percentage (98.6%) seen in Guatemala City. The findings warrant further study into
the causes oflow efficacy of prenatal ultrasound diagnoses third-world countries.

27

MANDIBULAR FRACTURE SURVEY: A 10-YEAR RETROSPECTIVE AND
PROSPECTIVE ANALYSIS
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Retrospective analysis of 10-years accumulation of cases at the Alameda County Medical
Center Highland Campus reveals insight into the demographics behind mandibular and oralmaxillofacial trauma. In 52 selected cases, spanning 10 years, a detailed data analysis was
gathered assessing various demographic features, such as age, sex, race, disease, substance
abuse, mechanism of injury, anatomical location of injury and treatment and follow-up. In a
preliminary evaluation on the topics, our study has shown a considerable correlation of trauma
with substance abuse, sex and race of the victim. Further investigative evaluations will allow us
to better understand the culture behind violence in an underdeveloped and impoverished
community.
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The purpose of this study is to examine the effect the addition of the intra oral camera has
to the standard protocol on preventive care on the self-care practice of pediatric patients between
ages 7 to 14 years of age in a pediatric dental clinic. Two similar patient groups will be studied.
Patients from both groups will receive a prophylaxis and topical fluoride from a dental student
(supervised by a clinical instructor). The indices to be used are DMFT scores, Modified
Gingival Index (Lobene) and OHI-S (Greene and Vermillion), which are currently used for all
patients as part of typical treatment protocol in the Pediatric Dental Clinic. At the end of the
preventive visit, a questionnaire will be given to the patient and parent to assess the effectiveness
of the intraoral camera as an adjunct to preventive care. When the patients return for their 6month recall visit, the DMFT scores, Gingival Index and Plaque Index will be compared.
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DEVELOPING AN ASSAY TO DETECT LIGAND BINDING TO THE COILED COIL
DOMAIN OF HIV-1 GP41
1

Ryan Savage and Miriam Gochin 2

Doctor of Dental Surgery Program 1 and Department ofMicrobiolog/, School of Dentistry,
University of the Pacific, 2155 Webster Street, San Francisco, CA 94115
INTRODUCTION: We are developing an assay to test for compounds which bind to the
coiled coil domain of the gp41 fusion protein ofHN, and may therefore act as potent antiviral
drugs. Currently there is a peptide, enfuvirtide, which has been FDA-approved for treatment, but
which suffers from the drawbacks of high cost and requiring parenteral administration. Once
developed, our assay will be used to rapidly screen large libraries of non-peptide compounds for
binding affinity.
METHOD:
There are two components comprising our assay. The first is a peptide
similar to enfuvirtide which should bind to the coiled coil and which we label with a fluorophore.
The second is a designed gp41 coiled coil, which has attached at its N-terminus a metal
coordination center that can absorb light emitted from the fluorophore. The binding event results
in quenching of fluorescence, which we monitor using a fluorimeter. Non-peptide compounds,
which bind competitively, can then be detected because they will cause the fluorescence to
mcrease.
GOALS:
We have carried out experiments to fine-tune the assay to determine (i) an
optimal fluorophore for use in the assay and (ii) the specificity of the peptide for the binding site
of the coiled coil.
RESULTS:
(i) We have determined that the fluorophore Lucifer Yellow has excellent
properties in sensitivity and wavelength of emission for our assay. (ii) We have found that
peptide binding is not completely specific, but that some non-specific hydrophobic effects play a
role in binding.
CONCLUSIONS:
Future work will include lengthening the peptide or coiled coil to improve
binding specificity or developing constrained peptides that present the correct side-chain
conformations into the binding site.

30

NOVEL TRANSFECTION REAGENTS FOR GENE THERAPY OF ORAL CANCER
1

Caton State , Nate Overlid2 , Krystyna Konopka2 and Nejat Duzgune~

2

1

Doctor of Dental Surgery Program and 2Department of Microbiology, School of Dentistry,
University of the Pacific, San Francisco, CA 94115

Oral squamous cell carcinoma (SCC) is the most common type of oral cancer: Nine out
ten oral cancer malignancies are SCCs. Current therapies of oral SCC are not highly effective,
with a 5 year survival rate of about 50% if detected early. Our long-term goal is to develop gene
therapy for oral SCC based on the delivery of the Herpes Simplex virus thymidine kinase
(HSV/tk) gene to SCC cells, followed by ganciclovir treatment to mediate cytotoxicity. As a
first step towards testing this strategy in an animal model of oral sec, the ability of novel
transfection reagents to deliver a reporter gene into human and murine sec cells was
investigated. The following transfection reagents were tested: 1) NeoPhectin (cationic
cardiolipin-based lipid), 2) JetPEI (linear polyethylenimine), 3) GeneJammer (proprietary
polyamine and other components), 4) Trojene (proprietary cationic lipid and a neutral helper
lipid), and 5) Metafectene (proprietary cationic lipid). These reagents were complexed with the
luciferase-expressing plasmid (pCMVluc) at varying ratios to determine optimal conditions for
delivery to human HSC-3 and murine SCC-7 cells. Gene delivery was monitored by the
expression ofluciferase in celllysates, expressed in relative light units (RLU)/ml oflysate. For
HSC-3 cells, the best reagent was found to be Trojene with an optimal ratio ofTrojene:DNA
()ll:)lg) of 4:1 . GeneJammer, NeoPhectin and JetPEI mediated much lower levels of gene
expression. For SCC-7 cells only Trojene and Metafectene were examined. Trojene was found
to be superior to Metafectene and the optimal reagent: DNA ratio was 2:1 ()11: )lg) for both.
Future experiments will examine the ability ofTrojene to deliver HSV/tk to SCC-7 cells and to
mediate cytotoxicity in the presence of ganciclovir.

31

ABSTRACTS
SENIOR RESEARCH
COMPETITION

32

SERUM-RESISTANT HSVTK/GANCICLOVIR GENE THERAPY IN ORAL CANCER
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OBJECTIVES:
Oral Squamous Cell carcinoma (OSCC) is the most prevalent cancer
involving the oral cavity and oropharynx. The purpose of this study was to deliver the Herpes
Simplex Virus thymidine kinase gene (HSV -tk) to HSC-3 human SCC cells, as a "suicide" gene
therapy approach. We examined the effect of fetal bovine serum (FBS) on the delivery of a
reporter gene and HSV -tk by the polyamine reagent, Gene Jammer, and the polycationic
liposome, Metafectene.
METHODS:
We assessed gene delivery by incubating HSC-3 cells with the plasmid
pCMV-luc and measuring luciferase activity in celllysates. Cells transfected with the HSV-tk
plasmid were incubated in the absence and the presence of ganciclovir (1 0 11g/ml) for the
indicated periods of time. We used the the Alamar blue assay to determine ganciclovir-specific
cytotoxicity to HSC-3 cells mediated by the plasmid pCMV-HSVtk. Mock-transfected cells
served as controls.
RESULTS:
The optimal ratios ofthe reagents to DNA for delivering the luciferase
gene were 4f.!l Metafectene:f.!g DNA and 6 or 12 f.!l GeneJammer:f.!g DNA. GeneJammermediated luciferase expression was inhibited by about 30% when transfection was performed in
the presence of 10% FBS. The delivery of the HSV-tk gene by Gene Jammer in the absence and
presence of 10% FBS, followed by ganciclovir treatment for 9 days, resulted in 100% and 70%
cytotoxicity, respectively. With Metafectene, FBS in the range 10-60% inhibited luciferase gene
expression by about 60%. Using HSVtk/ganciclovir, 90-100% cytotoxicity was observed in the
presence of 0 or 10% FBS. Even in the presence of 60% FBS, Metafectene mediated 50-70%
cytotoxicity, compared to controls.
CONCLUSION:
Our observations suggest that Metafectene may be useful for the gene
therapy ofOSCC in animal models. (This work was supported partially by Research Award
DRES03-027 from the School of Dentistry).
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Infection control has been one of the most important advances in dentistry in the past
thirty years. There are many disinfectants available to dental practitioners to maintain the
current standards of infection control. Several studies have examined the efficacy of
disinfectants on various hard surfaces. We examined the efficacy oftwo disinfectants (Ecotru
and Tricide) on three hard surfaces of a dental unit in a large dental school clinic. These three
surfaces include a bench top adjacent to the patient dental chair, a plastic computer screen used
to shield notebook computers from contamination, and the shoulder of the patient dental chair.
Bacterial samples were obtained from three surfaces often dental units after patients had been
dismissed from treatment. These surfaces were then disinfected with either Ecotru or Tricide
using the spray-wipe-spray method. Bacterial samples were then taken again. The culture media
used were blood agar plates and Hycheck slides containing a tryptic soy agar medium and a DE
neutralizing agar medium. These samples were then incubated for 48 hours at 36°C. Bacterial
colonies were quantified by placing the colony counts in one of five categories of bacterial
density: no colonies, very low, low, medium, and high. Although both disinfectants were
effective against bacteria on the dental unit hard surfaces, Ecotru appeared to be a more effective
disinfectant than Tricide.
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OBJECTIVES:
Endothelial-derived relaxing factors (EDRF's), such as nitric oxide (NO),
prostaglandins (PG) and endothelium-derived hyperpolarizing factor (EDHF) play a crucial role
in the regulation of blood flow. In the rat submandibular gland (SMG) blood flow is largely
under neural regulation, but EDRF 's also participate in the vasodilatation accompanying
secretion. The purpose of this study was to determine the relative contributions of NO, PG and
EDHF to parasympathetic vasodilatation in the SMG.
METHODS:
Male Sprague-Dawley rats (N=19, 350-450 grams) were used. Under
chloralose anesthesia, parasympathetic stimulation was delivered via the chorda-lingual nerve at
frequencies of 2, 5 and 10 Hz (5-6 V, 2 ms). Laser-Doppler flowmetry was used to measure
blood flow (perfusion units) in the presence or absence of inhibitors of NO synthase (L-NAME)
and PG synthesis (indomethacin). Blood pressure and salivary flow were also monitored. All
data were collected and analyzed using PowerLab software. Differences among treatments were
analyzed using a repeated ANOV A followed by post-hoc tests for differences between individual
means.
RESULTS:
In the absence of inhibitors, SMG blood flow (calculated as an integrated
area, minutes x perfusion) was 6,159 ± 4530 at 2Hz, 15,645 ± 6830 at 5Hz and 22,418 ± 7660
at 10Hz (p<0.01 5Hz vs 2Hz and 10Hz vs 5Hz). L-NAME (300 J.lg/min, i.v.) partially blocked
parasympathetic vasodilatation (45% at 2Hz, and 30% at both 5 Hz and 10Hz, p<0.01). The
addition of indomethacin (1 mg/kg, i.p.) led to a further decrease in vasodilatation (p<0.05 LNAME +indomethacin vs L-NAME) to 65% of controls at 2Hz, 46% at 5 Hz and 34% at 10Hz.
CONCLUSIONS:
Parasympathetic vasodilatation in the SMG depends, in part, on both NO
and PG. EDHF also contributes to the observed vasodilatation, particularly at higher stimulation
frequencies.
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Oral squamous cell carcinoma (OSCC) is the sixth most common cancer in the United
States. Gene therapy approaches are being used in preclinical studies for the treatment of OSCC.
Our laboratory is working on methods to enhance gene delivery to OSCC cells in culture as a
first step toward the delivery of the Herpes Simplex Virus thymidine kinase (HSV -tk) "suicide
gene" in an animal model of the disease. Cationic liposome-DNA complexes (lipoplexes) are a
promising non-viral vector for the gene therapy of oral cancer. During gene delivery, it is
important to protect DNA from nucleases and to condense it to form a compact complex with
cationic liposomes. Protamine is an arginine-rich, natural cationic peptide ofMW 4000-4250 that
condenses DNA. Transferrin-complexed lipoplexes have been shown to enhance gene delivery to
a variety of cells, including HSC-3 human squamous cell carcinoma cells, possibly via binding to
transferrin receptors.
We examined whether protamine could enhance gene delivery to HSC-3 cells by Transferrinlipoplexes. We also investigated whether HSV -tk/ganciclovir mediated cytotoxicity in these
cells. Lipoplexes were prepared by the complexation of transferrin and protamine with
DOTAP/Cholesterolliposomes followed by association of plasmid DNA (pCMVluc) encoding
the marker enzyme luciferase. The presence of protamine in the range 0.5-2 microgram per
microgram DNA enhanced luciferase expression 3-4 fold, depending on the DOTAP/DNA (+/-)
charge ratio. HSV-tk/ganciclovir-mediated cytotoxicity in HSC-3 cells was also enhanced by the
association of protamine with transferrin-lipoplexes, increasing the percentage of cells killed
from 62% to 100% by the 91h day of the experiment. These results suggest that condensation of
DNA by protamine can be useful in both gene delivery and gene therapy applications.
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